Schedule 13G ownership disclosure

DiaMedica Therapeutics Inc

Voting common shares, no par value per share · CUSIP: 25253X207

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Dialectic Life Sciences SPV LLC

    Shares: 0.00 · Class: 0%

  • Dialectic LS Manager LLC

    Shares: 0.00 · Class: 0%

  • Dialectic Capital Management, LP

    Shares: 0.00 · Class: 0%

  • Dialectic Partners, LLC

    Shares: 0.00 · Class: 0%

  • John Fichthorn

    Shares: 153,983.00 · Class: 0.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-26-001133
Form type
SCHEDULE 13G/A
Filer
DIALECTIC CAPITAL MANAGEMENT, LP
CIK
CIK 1411512
Filed
Feb 17, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub